Results 31 to 40 of about 2,565 (197)

Pertactin-deficient isolates: evidence of increased circulation in Europe, 1998 to 2015. [PDF]

open access: yesEurosurveillance, 2019
IntroductionPertussis outbreaks have occurred in several industrialised countries using acellular pertussis vaccines (ACVs) since the 1990s.
Berbers, Guy   +19 more
core   +7 more sources

Pertactin-Negative and Filamentous Hemagglutinin-Negative Bordetella pertussis, Australia, 2013–2017

open access: yesEmerging Infectious Diseases, 2019
During the 2008–2012 pertussis epidemic in Australia, pertactin (Prn)–negative Bordetella pertussis emerged. We analyzed 78 isolates from the 2013–2017 epidemic and documented continued expansion of Prn-negative ptxP3 B. pertussis strains.
Zheng Xu   +9 more
doaj   +5 more sources

Crystallization and preliminary X-ray diffraction analysis of P30, the transmembrane domain of pertactin, an autotransporter fromBordetella pertussis

open access: green, 2007
P30, the 32 kDa transmembrane C-terminal domain of pertactin from Bordetella pertussis, is supposed to form a β-barrel inserted into the outer membrane for the translocation of the passenger domain.
Yanshi Zhu   +3 more
openalex   +3 more sources

Structure of Bordetella pertussis virulence factor P.69 pertactin

open access: yesNature, 1996
A new generation of whooping-cough vaccines contain P.69 pertactin, a surface-exposed domain of an outer membrane protein expressed by the virulent bacterium Bordetella pertussis.
Paul Emsley   +11 more
core   +3 more sources

Pertactin-Negative Variants of Bordetella pertussis in the United States [PDF]

open access: bronzeNew England Journal of Medicine, 2013
In 12 B. pertussis isolates from children in Philadelphia, 11 were negative for the pertactin antigen that is a component of the acellular vaccine. Such variants may reflect selection pressure from the vaccine and may reduce its effectiveness for preventing whooping cough.
Anne Marie Queenan   +2 more
openalex   +4 more sources

Virulence of Pertactin-Negative Bordetella pertussis Isolates from Infants, France

open access: yesEmerging Infectious Diseases, 2013
Bordetella pertussis isolates that do not express pertactin (PRN) are increasing in regions where acellular pertussis vaccines have been used for >7 years. We analyzed data from France and compared clinical symptoms among infants
Hélène Bodilis, Nicole Guiso
doaj   +2 more sources

Virulence of Pertactin-NegativeBordetella pertussisIsolates from Infants, France [PDF]

open access: diamondEmerging Infectious Diseases, 2013
Bordetella pertussis isolates that do not express pertactin (PRN) are increasing in regions where acellular pertussis vaccines have been used for >7 years. We analyzed data from France and compared clinical symptoms among infants
Hélène Bodilis, Nicole Guiso
openalex   +4 more sources

Antimicrobial Susceptibility of Pertactin-Producing and Pertactin-Deficient Strains of Bordetella pertussis From 2007 to 2014

open access: goldOpen Forum Infectious Diseases, 2015
Emily Souder   +4 more
openalex   +2 more sources

Rapid Identification of Bordetella pertussis Pertactin Gene Variants Using LightCycler Real-Time Polymerase Chain Reaction Combined with Melting Curve Analysis and Gel Electrophoresis

open access: yesEmerging Infectious Diseases, 2001
Recently, eight allelic variants of the pertactin gene (prn1-8) have been characterized in Bordetella pertussis strains isolated in Europe and the United States.
Johanna Mäkinen   +4 more
doaj   +2 more sources

Pertactin-Deficient Bordetella pertussis, Vaccine-Driven Evolution, and Reemergence of Pertussis [PDF]

open access: yesEmerging Infectious Diseases, 2021
Recent reemergence of pertussis (whooping cough) in highly vaccinated populations and rapid expansion of Bordetella pertussis strains lacking pertactin (PRN), a common acellular vaccine antigen, have raised the specter of vaccine-driven evolution and ...
Longhuan Ma   +3 more
doaj   +3 more sources

Home - About - Disclaimer - Privacy